Advertisement
New Zealand markets closed
  • NZX 50

    12,457.41
    -34.17 (-0.27%)
     
  • NZD/USD

    0.6342
    +0.0013 (+0.20%)
     
  • NZD/EUR

    0.5675
    +0.0018 (+0.31%)
     
  • ALL ORDS

    8,476.80
    +14.00 (+0.17%)
     
  • ASX 200

    8,212.20
    +8.50 (+0.10%)
     
  • OIL

    68.64
    +0.97 (+1.43%)
     
  • GOLD

    2,680.80
    -14.10 (-0.52%)
     
  • NASDAQ

    20,008.62
    -106.91 (-0.53%)
     
  • FTSE

    8,320.76
    +35.85 (+0.43%)
     
  • Dow Jones

    42,313.00
    +137.89 (+0.33%)
     
  • DAX

    19,473.63
    +235.27 (+1.22%)
     
  • Hang Seng

    20,632.30
    +707.72 (+3.55%)
     
  • NIKKEI 225

    39,829.56
    +903.93 (+2.32%)
     
  • NZD/JPY

    90.1570
    -1.4180 (-1.55%)
     

Is It Time To Consider Buying Xylem Inc. (NYSE:XYL)?

Today we're going to take a look at the well-established Xylem Inc. (NYSE:XYL). The company's stock saw significant share price movement during recent months on the NYSE, rising to highs of US$142 and falling to the lows of US$126. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Xylem's current trading price of US$133 reflective of the actual value of the large-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Xylem’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

View our latest analysis for Xylem

What's The Opportunity In Xylem?

The stock seems fairly valued at the moment according to our valuation model. It’s trading around 19% below our intrinsic value, which means if you buy Xylem today, you’d be paying a fair price for it. And if you believe that the stock is really worth $165.16, then there’s not much of an upside to gain from mispricing. So, is there another chance to buy low in the future? Given that Xylem’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us an opportunity to buy later on. This is based on its high beta, which is a good indicator for share price volatility.

Can we expect growth from Xylem?

earnings-and-revenue-growth
earnings-and-revenue-growth

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. Xylem's earnings over the next few years are expected to increase by 59%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

What This Means For You

Are you a shareholder? XYL’s optimistic future growth appears to have been factored into the current share price, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough confidence to invest in the company should the price drop below its fair value?

Are you a potential investor? If you’ve been keeping tabs on XYL, now may not be the most optimal time to buy, given it is trading around its fair value. However, the positive outlook is encouraging for the company, which means it’s worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

Diving deeper into the forecasts for Xylem mentioned earlier will help you understand how analysts view the stock going forward. So feel free to check out our free graph representing analyst forecasts.

If you are no longer interested in Xylem, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.